Compounds > buserelin
Page last updated: 2024-08-23

buserelin and Diabetes Mellitus, Type 1

buserelin has been researched along with Diabetes Mellitus, Type 1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuseya, T; Horibe, S; Imai, A; Takagi, A; Takagi, H; Tamaya, T1
Balint-Perić, L; Prelević, GM; Wurzburger, MI1

Other Studies

2 other study(ies) available for buserelin and Diabetes Mellitus, Type 1

ArticleYear
A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient.
    European journal of obstetrics, gynecology, and reproductive biology, 1998, Volume: 76, Issue:1

    Topics: Adult; Blood Glucose; Buserelin; Danazol; Diabetes Mellitus, Type 1; Endometriosis; Estrogen Antagonists; Female; Glycated Hemoglobin; Humans

1998
The effect of somatostatin analog octreotide (Sandostatin) on luteinizing hormone and ovarian steroids in insulin-dependent diabetic women without residual insulin secretion.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1992, Volume: 6, Issue:4

    Topics: Adult; Androstenedione; Buserelin; Diabetes Mellitus, Type 1; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Secretion; Luteinizing Hormone; Octreotide; Ovary; Periodicity; Steroids; Testosterone

1992